Pan-EphB tyrosine kinase inhibitor mitigates diabetic cardiomyopathy
Heba A. Ewida, Md Tareq Aziz, Syed Tareq, Prasanth K. Chelikani, Mahmoud Salama Ahmed
This study shows that STA-013, a pan-EphB tyrosine kinase inhibitor, improves cardiac function and reduces fibrosis in a diabetic mouse model.
bioRxiv · Nov 17, 2025 · PreprintPharmacology & Toxicology